Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $-78.35M.
ENTERPRISE VALUE (EV)
$-78.35M
Xilio Therapeutics, Inc.
Market Cap
$59.18M
Enterprise Value (EV)
$-78.35M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Xilio Therapeutics, Inc. (XLO) | $59.18M | $-78.35M |
| Oncolytics Biotech Inc. (ONCY)vs › | $60.02M | $56.35M |
| Kalaris Therapeutics Inc (KLRS)vs › | $60.24M | $18.47M |
| Fractyl Health, Inc. (GUTS)vs › | $60.42M | $74.01M |
| MiNK Therapeutics, Inc. (INKT)vs › | $58.94M | $50.13M |
| PDS Biotechnology Corporation (PDSB)vs › | $58.44M | $57.21M |
| Adicet Bio, Inc. (ACET)vs › | $58.43M | $38.15M |
| Boundless Bio, Inc. (BOLD)vs › | $57.76M | $37.55M |
| Talphera, Inc. (TLPH)vs › | $57.61M | $56.87M |
| Connect Biopharma Holdings Limited (CNTB)vs › | $57.01M | $30.59M |
Market Cap
$59.18M
Total Debt
$0.00
Cash
$137.53M
Enterprise Value
$-78.35M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
